EDRN Prostate & Urogenital Cancers Collaborative Group Meeting

Friday, September 29, 2023

8:00 a.m. to 10:00 a.m. Eastern Time

Room: Explore-Empower

Chair: (Virtual) John Semmes, PhD, Eastern Virginia Medical School

Co-chair: (In-person) Jeff Tosoian, MD, Vanderbilt University Medical Center

NCI Program Directors: (In-person) Indu Kohaar, PhD and (In-person) Richard Mazurchuk, PhD, National Cancer Institute

Draft Agenda

8:00 a.m. 10:00 a.m.

Progress Reports by Earlier Funded Sites

Presentations will highlight progress, proposed collaborative projects, and future directions

8:00 a.m. – 8:20 a.m.

01: Michigan-VUMC Biomarker Characterization Center

  • (In-person) Jeffrey J Tosoian, MD, MPH Vanderbilt University Medical Center
  • (In-person) Arul M Chinnaiyan, MD, PhD University of Michigan

8:20 a.m. – 8:30 a.m.


8:30 a.m. – 8:50 a.m.

02: Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern

(In-person) Martin G. Sanda, MD, Emory University

8:50 a.m. – 9:00 a.m.


9:00 a.m. – 9:20 a.m.

03: NCI EDRN MRI Biomarker Study and Reference Set (PMRI)

(Virtual) John T. Wei, MD, MS, University of Michigan

9:20 a.m. – 9:30 a.m.


9:30 a.m. – 9:50 a.m.

04: BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs

(In-person) Daniel W. Chan, PhD, Johns Hopkins University

9:50 a.m. – 10:00 a.m.


10:00 a.m.